Healthcare

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

What Patients Need Next and Who Will Deliver It

Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

Conducted monthly in 29 countries among a panel of over 20,000 adults for more than a decade, What Worries the World survey offers an exceptional snapshot of world opinion on pressing global issues.

In this Ipsos Point of View, discover how to harness AI's speed without falling into the confidence trap.

Longevity medicine is changing physician-patient dynamics. Download our framework for healthcare professionals navigating new patient expectations and structural barriers.

How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.

Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?